Deals
Latham helps close $70.5B Allergan sale
Latham & Watkins LLP represented Irvine-based Botox maker Allergan Inc. in its $70.5 billion cash and equity sale to Actavis PLC. The deal closed on Tuesday.
Actavis, based in Dublin, Ireland, said it will change its global name to Allergan, pending shareholder approval, sometime this year.
Partners Cary K. Hyden and Michael A. Treska in Costa Mesa an...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In